AbCellera Biologics Inc. ABCL

Set alert

12.18 USD +1.06 (+9.53%)

At closeNov 3, 2026, 4:00 PM EST

12.18 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

11.28 Day range 12.33

2.75 52-week range 15.02

Held by insiders 21.74%

Held by institutions 36.69%

Float held by institutions 46.88%

Institutions 189

Top institutional holders
Holder	% held	Shares	Value	Reported
Baker Bros. Advisors, LP	10.77%	33,012,138	402.09M	Jun 29, 2026
Capital World Investors	4.43%	13,588,349	165.51M	Jun 29, 2026
Two Sigma Investments, LP	3.40%	10,437,431	127.13M	Jun 29, 2026
TD Waterhouse Canada Inc.	3.01%	9,222,005	112.32M	Sep 29, 2026
Bank of America Corporation	2.00%	6,141,539	74.80M	Jun 29, 2026
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1.41%	4,317,206	52.58M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SmallCap World Fund Inc	4.31%	13,228,596	161.12M	Sep 29, 2026
iShares Trust-iShares Biotechnology ETF	0.63%	1,945,418	23.70M	Sep 29, 2026
BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio	0.41%	1,257,977	15.32M	Aug 30, 2026
T. Rowe Price New Horizons Fund, Inc.	0.34%	1,053,900	12.84M	Jun 29, 2026
NORTHERN LIGHTS FUND TRUST III-Counterpoint Quantitative Equity ETF	0.32%	971,643	11.83M	Jun 29, 2026
iShares Trust-iShares Genomics Immunology and Healthcare ETF	0.20%	625,386	7.62M	Sep 29, 2026

ABCL insiders
Insider	Relation	Latest transaction	Date	Shares held
BOOTH ANDREW	Chief Financial Officer	Purchase	Aug 13, 2026	613,759
HANSEN CARL L.G.	Chief Executive Officer	Conversion of Exercise of derivative security	Nov 24, 2024	56,984,000
HAYDEN MICHAEL REUBEN	Director	Purchase	Aug 23, 2026	0
MONTALBANO JOHN S.	Director	Purchase	Aug 17, 2026	256,000
THERMOPYLAE HOLDINGS, LTD.	Beneficial Owner of more than 10% of a Class of Security	Purchase	Feb 26, 2026	56,134,100

Held by funds